Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|October 23, 2018
MiR-19b non-canonical binding is directed by HuR and confers chemosensitivity through regulation of P-glycoprotein in breast cancerJames L Thorne, Sebastiano Battaglia, Diana E Baxter, et al.
Nucleic Acids Research|November 20, 2010
Epigenetic control of a VDR-governed feed-forward loop that regulates p21(waf1/cip1) expression and function in non-malignant prostate cellsJames L Thorne, Orla Maguire, Craig L Doig, et al.
Biochemical Pharmacology|August 18, 2021
Pharmacologic and genetic inhibition of cholesterol esterification enzymes reduces tumour burden: A systematic review and meta-analysis of preclinical modelsAlex Websdale, Yi Kiew, Philip Chalmers, et al.
Carcinogenesis|October 23, 2012
Recruitment of NCOR1 to VDR target genes is enhanced in prostate cancer cells and associates with altered DNA methylation patternsCraig L Doig, Prashant K Singh, Vineet K Dhiman, et al.
The Journal of Pathology|August 14, 2013
MiR-26b is down-regulated in carcinoma-associated fibroblasts from ER-positive breast cancers leading to enhanced cell migration and invasionEldo T Verghese, Ruth Drury, Caroline A Green, et al.
BMC Cancer|September 13, 2015
Chemotherapy induces Notch1-dependent MRP1 up-regulation, inhibition of which sensitizes breast cancer cells to chemotherapyBaek Kim, Sam L Stephen, Andrew M Hanby, et al.
Oncogene|March 20, 2021
Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancerSamantha A Hutchinson, Alex Websdale, Giorgia Cioccoloni, et al.
Carcinogenesis|May 15, 2010
Elevated NCOR1 disrupts PPARalpha/gamma signaling in prostate cancer and forms a targetable epigenetic lesionSebastiano Battaglia, Orla Maguire, James L Thorne, et al.
British Journal of Cancer|July 13, 2021
Transcriptome profiles of stem-like cells from primary breast cancers allow identification of ITGA7 as a predictive marker of chemotherapy responseNoha Gwili, Stacey J Jones, Waleed Al Amri, et al.
Pageof 4